Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • GNS Healthcare Announces $10M Financing, MMRF Study Results

    Dec 8, 2015, 17:15 PM by Michael Croft

    Bio-IT World | GNS Healthcare announced a $10M Series C financing round today. Earlier this week, the Multiple Myeloma Research Foundation (MMRF) announced preliminary results of a multi-year collaboration with GNS to speed the discovery of innovative treatments for patients with multiple myeloma. 

    Full story
  • DIAGNOMICS AND MAVERIX ACHIEVE CLIA VALIDATION FOR CLINICAL DIAGNOSTIC PRE-NATAL TESTING

    Dec 8, 2015, 10:36 AM by Michael Croft
    SAN MATEO, CA - Dec 8, 2015 - Maverix Biomics, Inc., a leading genomic analysis software company, and Diagnomics, a developer of innovative products and services for personalized medicine based on Next Generation Sequencing (NGS) technology, today announced their achievement of Clinical Laboratory Improvement Amendments (CLIA) validation for NGS based Pre-natal Testing using the Maverix Dx Platform
    Full story
  • Googles Life Sciences division is now called Verily

    Dec 8, 2015, 09:10 AM by Michael Croft
    Computerworld | Google's parent company, Alphabet, has renamed its life sciences division Verily and given it the goal to "understand disease at the individual level."
    Full story
  • Certara Launches Version 15 of its Simcyp Population-based Simulator

    Dec 8, 2015, 08:42 AM by Michael Croft
    PRINCETON, NJ - Dec 8, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced the release of version 15 of its Simcyp® Population-based Simulator
    Full story
  • Roche and SQZ Biotech Pair Up on Immuno-Oncology

    Dec 7, 2015, 11:45 AM by Michael Croft
    FierceBiotech | Roche will invest as much as $500 million in a partnership with SQZ, based on a technology that physically manipulates immune cells to admit new antigens, with the aim of training these cells to fight a patient's own cancer.
    Full story
  • 'Kill Switches' for Genetically Modified Microbes

    Dec 7, 2015, 11:40 AM by Michael Croft
    Wired | Biologists at MIT have engineered new genetic elements to insert in bacteria, making these microbes dependent on lab-supplied synthetic molecules to survive.
    Full story
  • Should DNA donors see their genomic data?

    Dec 4, 2015, 17:13 PM by Michael Croft
    Nature News & Comment | Geneticist Charles Danko turned to Twitter this week for help in convincing his IRB at Cornell that he should be allowed to let his study participants download their genetic information
    Full story
  • Data Storage on DNA Can Keep It Safe for Centuries

    Dec 4, 2015, 09:49 AM by Michael Croft
    The New York Times | Scientists have shown that DNA molecules can be the basis for a long-term storage system potentially capable of holding all of the world's digital information in a tiny space.
    Full story
  • Shimadzu Introduces New ATHAP Matrix Kits for Improved Characterization of Hydrophobic Peptides and Proteins

    Dec 3, 2015, 16:08 PM by Michael Croft
    COLUMBIA, MD - Dec 3, 2015 - Shimadzu Scientific Instruments (SSI) has introduced ATHAP MALDI matrix kits to improve the detection of hydrophobic proteins or peptides containing transmembrane domains
    Full story
  • November News and Product Briefs

    Dec 3, 2015, 15:50 PM by Michael Croft
    Bio-IT World | News and product launches from around the industry, including CRISPR experiments in the cloud lab, and a machine learning venture for searching the scientific literature.
    Full story
  • What’s the Answer? (Dare we edit the human race?) #GeneEditSummit

    Dec 3, 2015, 10:58 AM by Michael Croft
    The OpenHelix Blog | This week's question is a biggie. And there's no answer yet. But that is the topic of the National Academies big event this week, International Summit on Human Gene Editing.
    Full story
  • Zhang Lab Produces Engineered CRISPR Complex with Greater Precision

    Dec 3, 2015, 10:10 AM by Michael Croft
    Bio-IT World | Scientists working at Feng Zhang's lab at the Broad Institute of MIT and Harvard have used insights about Cas9's structure and domains of DNA interaction to produce a mutant molecule, just as capable of cutting chosen DNA sequences, but with lower risk of making off-target cuts in distant areas of the genome.
    Full story
  • Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

    Dec 3, 2015, 07:28 AM by Michael Croft
    LONDON, UNITED KINGDOM - Dec 4, 2015 - Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually Digital Surgical Simulator Touch Surgery collaborates with Experts Surgeons at International Institutions (Stanford, Harvard Yale, Dartmouth, Vanderbilt, Imperial College London,& Others) to Create Surgical Simulations
    Full story
  • Microsoft and HP offer more info about their cloud partnership

    Dec 1, 2015, 14:54 PM by Michael Croft
    Computerworld | Hewlett Packard Enterprise outlined new details about its hybrid cloud partnership with Microsoft in an announcement Tuesday, saying it will provide a new hardware product that integrates with the Azure cloud platform and build its software to take advantage of Microsoft's offerings.
    Full story
  • Efforts to ‘Turbocharge’ Rice and Reduce World Hunger Enter Important New Phase

    Dec 1, 2015, 12:01 PM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Dec 1, 2015 - A long-term project aimed at improving photosynthesis in rice is entering its third stage, marking another step on the road to significantly increased crop yields that will help meet the food needs of billions of people across the developing world
    Full story
  • Certara Acquires Quantitative Systems Pharmacology Consultancy XenologiQ; Professor Piet van der Graaf to Lead New QSP Organization

    Dec 1, 2015, 10:58 AM by Michael Croft
    PRINCETON, NJ - Dec 1, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that it has acquired XenologiQ, a UK-based quantitative systems pharmacology (QSP) consultancy
    Full story
  • Human Longevity Acquires Cypher Genomics, Genomics Interpretation Software

    Nov 30, 2015, 15:45 PM by Michael Croft
    Bio-IT World | Human Longevity this morning announced that it has acquired Cypher Genomics for an undisclosed amount. Cypher has 14 employees who will join HLI including Cypher CEO and Co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI's Pediatric Business.
    Full story
  • Microbiome Startup uBiome Will Sequence Poop for the CDC

    Nov 30, 2015, 15:34 PM by Michael Croft
    Wired | uBiome has announced a partnership with the Centers for Disease Control and Prevention to develop a standardized way of measuring disruptions and changes to the human microbiome.
    Full story
  • Systematic CRISPR Knockouts in Cancer Cell Lines

    Nov 30, 2015, 10:58 AM by Michael Croft
    The Atlantic | CRISPR-Cas9 experiments are revealing which human genes are essential, and which matter specifically to cancer cells.
    Full story
  • Engineering a Promising Drug Candidate for Alzheimer's Disease

    Nov 30, 2015, 03:31 AM by Michael Croft
    ULSAN, SOUTH KOREA - Nov 24, 2015 - Alzheimer's disease (AD) is one of the most well-known and common form of dementia. It is also a progressive, degenerative brain disease whose cause is not fully understood, however, amyloid-β (Aβ) peptides, metal ions and reactive oxygen species (ROS) have been suggested to be involved in AD pathogenesis
    Full story
  • «
  • 351
  • 352
  • 353
  • 354
  • 355
  • 356
  • 357
  • 358 (current)
  • 359
  • 360
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy